ICH E6(R3) Is Here: What Your Centralized Monitoring Strategy Needs Right Now

The finalization of ICH E6(R3) marks a shift from theoretical risk management to a strict regulatory mandate, codifying Quality by Design and centralized monitoring as essential pillars of trial oversight. While operational tasks can be outsourced, the core tenet of this update is that ultimate accountability for data integrity and participant safety rests solely with the sponsor. This requires a move away from passive reporting toward active, continuous engagement with study data to ensure Critical-to-Quality factors are monitored in real time. For many organizations, the challenge lies in implementing proportionate oversight without the administrative weight of enterprise-grade tools. By utilizing a unified data layer and study-specific dashboards that surface human-readable logic, teams can maintain a transparent, visual audit trail that stands up to regulatory scrutiny. This approach ensures that oversight is a robust mechanism for surfacing localized risks before they compromise study outcomes, allowing sponsors to meet rigorous demands while remaining agile. Watch the full session to learn how to bridge the gap between regulatory requirements and practical implementation.